ArticleFrontiers in nutrition2026
Association between triglyceride-to-high-density lipoprotein cholesterol ratio and albuminuria in patients with type 2 diabetes: a cross-sectional study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Previous studies have demonstrated that the triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C) ratio is closely related to chronic kidney disease and albuminuria. However, the evidence linking TG/HDL-C ratios to albuminuria among individuals with type 2 diabetes (T2D) remains limited. Given the heightened susceptibility of this high-risk population to kidney and cardiovascular ailments, this study concentrated on individuals with T2D to investigate the association between TG/HDL-C and albuminuria. Methods: A total of 2,323 people diagnosed with T2D participated in this cross-sectional research. The relationship between TG/HDL-C and albuminuria prevalence was evaluated using logistic regression analysis. Restricted cubic spline (RCS) models were applied to identify nonlinear relationships. The ability of TG/HDL-C versus other markers to distinguish albuminuria was examined using receiver operating characteristic (ROC) curves. Further subgroup analyses were conducted to explore heterogeneity across different populations. In addition, we explored whether serum uric acid (SUA) and fasting blood glucose (FBG) accounted for part of the association between TG/HDL-C and albuminuria. Results: The albuminuria group and the non-albuminuria group showed a significant difference in TG/HDL-C. Additionally, the prevalence of albuminuria increased progressively across ascending quartiles of TG/HDL-C. RCS curve analysis revealed that albuminuria and TG/HDL-C do not follow a linear relationship (P-overall < 0.001; P-nonlinear < 0.001), with a threshold observed at a TG/HDL-C ratio of 2.08. Furthermore, TG/HDL-C demonstrated relatively higher discrimination, particularly in women. Subgroup analysis indicated that among female T2D patients, TG/HDL-C was more strongly linked to UACR. Exploratory mediation analysis suggested that blood glucose and oxidative stress may contribute to the indirect pathway linking TG/HDL-C and albuminuria. Conclusion: In conclusion, the TG/HDL-C ratio was positively associated with the prevalence of albuminuria in patients with T2D. However, causal inference is limited by the cross-sectional design. Further prospective studies are needed to confirm our findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.